The anti‐infection drug furazolidone inhibits NF‐κB signaling and induces cell apoptosis in small cell lung cancer
Abstract Targeting nuclear factor kappa B (NF‐κB) signaling pathway has become a promising strategy for the development of new antitumor drugs. In this paper, we found that anti‐infection drug furazolidone (FZD) could significantly inhibit NF‐κB‐driven luciferase activity, and FZD could markedly inh...
Main Authors: | Jin‐Guo Yu, Cheng‐Hong Ji, Min‐Hua Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/kjm2.12281 |
Similar Items
-
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
by: Avgi Tsolou, et al.
Published: (2017-06-01) -
NFκB signaling in alveolar rhabdomyosarcoma
by: Megan M. Cleary, et al.
Published: (2017-09-01) -
NFκB signalling in colorectal cancer: Examining the central dogma of IKKα and IKKβ signalling
by: Molly McKenzie, et al.
Published: (2024-06-01) -
Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells
by: Peng Deng, et al.
Published: (2016-04-01) -
MicroRNA-429 inhibits neuroblastoma cell proliferation, migration and invasion via the NF-κB pathway
by: Xianjun Zhou, et al.
Published: (2020-02-01)